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Abstract
Background: Psychological interventions for the prevention of depression might be a cost-effective way to reduce the burden
associated with depressive disorders.
Objective: To evaluate the cost-effectiveness of a Web-based guided self-help intervention to prevent major depressive disorder
(MDD) in people with subthreshold depression (sD).
Methods: A pragmatic randomized controlled trial was conducted with follow-up at 12 months. Participants were recruited
from the general population via a large statutory health insurance company and an open access website. Participants were
randomized to a Web-based guided self-help intervention (ie, cognitive-behavioral therapy and problem-solving therapy assisted
by supervised graduate students or health care professionals) in addition to usual care or to usual care supplemented with Web-based
psycho-education (enhanced usual care). Depression-free years (DFYs) were assessed by blinded diagnostic raters using the
telephone-administered Structured Clinical Interview for DSM-IV Axis Disorders at 6- and 12-month follow-up, covering the
period to the previous assessment. Costs were self-assessed through a questionnaire. Costs measured from a societal and health
care perspective were related to DFYs and quality-adjusted life years (QALYs).
Results: In total, 406 participants were enrolled in the trial. The mean treatment duration was 5.84 (SD 4.37) weeks. On average,
participants completed 4.93 of 6 sessions. Significantly more DFYs were gained in the intervention group (0.82 vs 0.70). Likewise,
QALY health gains were in favor of the intervention, but only statistically significant when measured with the more sensitive
SF-6D. The incremental per-participant costs were €136 (£116). Taking the health care perspective and assuming a
willingness-to-pay of €20,000 (£17,000), the intervention’s likelihood of being cost-effective was 99% for gaining a DFY and
64% or 99% for gaining an EQ-5D or a SF-6D QALY.
Conclusions: Our study supports guidelines recommending Web-based treatment for sD and adds that this not only restores
health in people with sD, but additionally reduces the risk of developing a MDD. Offering the intervention has an acceptable
likelihood of being more cost-effective than enhanced usual care and could therefore reach community members on a wider scale.
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Trial registration: German Clinical Trials Register: DRKS00004709; http://www.drks.de/DRKS00004709 (Archived by
WebCite at http://www.webcitation.org/6kAZVUxy9)
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Introduction
Currently, major depressive disorder (MDD) is one of the
leading causes of years lived with disability [1] and is further
associated with substantial economic costs for society [2]. In
high-income countries, the 12-month prevalence of MDD is
estimated at 5.1% [3] with an annual incidence rate of 3% [4].
This implies that close to 60% of the depressed cases are new
cases, which underscores the importance of both treatment and
prevention of depression to reduce its disease burden. In fact,
even when assuming full coverage of evidence-based treatments,
approximately only one third of the disease burden could be
averted [5,6]. In this context, attention has shifted to the
prevention of MDD as an additional option to foster further
reductions of depression’s disease burden by reducing the
development of new cases.
Meta-analyses provide evidence for the effectiveness of
psychological interventions to prevent first onsets and
recurrences in depression [7-9]. Especially indicated prevention,
targeting subthreshold symptoms of an emerging depression,
appears to be particularly effective [8]. People are then screened
for subthreshold depression (sD) not meeting the diagnostic
criteria for a full-blown depressive disorder and are subsequently
offered a preventive intervention. However, research on the
cost-effectiveness of depression prevention is still limited.
Economic evaluations conducted alongside randomized trials
and economic evaluation studies using decision analytic
modeling techniques suggest that preventive interventions for
depression can be very cost-effective [10-13]. Research on how
to deliver such interventions on a large scale to the community
is scant. Using the Internet to provide community members with
effective preventive interventions is currently viewed as a
potentially cost-effective way of scaling up preventive
interventions [14,15]. Web-based interventions are scalable.
Scalability refers to the ability of the intervention shown to be
effective in a research setting to be expanded under real world
conditions. To reach a greater proportion of the eligible
population while retaining effectiveness, only a small increase
in therapeutic resources is required. Thus, the marginal cost per
additional user get lower via an economies of scale effect.
Economies of scale might also reduce variable costs (ie,
therapist’s support per participant) because therapists become
more efficient through better organization and experience.
To the best of our knowledge, no randomized controlled trial
has investigated the cost-effectiveness of a Web-based guided
self-help intervention to prevent the onset of diagnosed MDD.
Elsewhere we reported the primary outcomes with respect to
progression to MDD at 12 months [16]. Here we will evaluate
the cost-effectiveness and cost-utility of the Web-based
intervention among self-selected members from the community
suffering from sD.
Methods
Study Design
We conducted and reported the health-economic evaluation in
agreement with the Consolidated Health Economic Evaluation
Reporting Standards statement [17] and the guidelines from the
International Society for Pharmacoeconomics and Outcomes
Research [18]. We conducted the economic evaluation with a
12-month time horizon from both a societal and a public health
care perspective alongside a 2-armed pragmatic randomized
controlled trial in Germany to establish the cost-effectiveness
and cost-utility of an indicated Web-based guided self-help
intervention in conjunction to usual care for people with sD as
compared with enhanced usual care (ie, Web-based
psycho-education in addition to treatment as usual). Whereas
the societal perspective included all costs and consequences
regardless by whom they were incurred, the health care system
perspective only considers direct medical costs. Full details of
the trial design can be found elsewhere [19]. The study was
approved by the medical ethics committee of the University of
Marburg (reference number AZ 2012-35K) and registered under
DRKS00004709 in the German clinical trial registry.
Participants
In total, 406 participants were included in the study. Participants
were recruited from March 2013 to March 2014 from the general
population via a large German health insurance company and
through newspaper articles, on-air media, and related websites.
We chose this open recruitment strategy as it reflects the clinical
practice for this type of intervention, thus enhancing the trial’s
ecological validity. As we conducted a pragmatic trial, the use
of antidepressant medication was allowed as part of
care-as-usual. However, participants needed to be on a stable
dose for at least four weeks to be able to enter the study.
Textboxes 1 and 2 present participant eligibility for inclusion
and exclusion in the study.
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Textbox 1. Inclusion criteria for the study.
• Age 18 years and above
• Subthreshold depression (sD) (Centre for Epidemiological Studies Depression Scale (CES-D)≥16) as having some depressive symptoms not
meeting the diagnostic criteria for a full-blown DSM-IV major depressive disorder (MDD) as assessed by the telephone-administered Structured
Clinical Interview for DSM-IV (SCID)
• Internet access
• Informed consent
Textbox 2. Exclusion criteria for the study.
• Meeting DSM-IV criteria for bipolar disorder or psychotic disorder
• Having a history of a major depressive disorder (MDD) in the past 6 months based on Kupfer’s model [20]
• Currently receiving psychotherapy for any kind of mental health problem
• Being on a waiting list for psychotherapy
• Having received psychotherapeutic treatment in the past 6 months
• Showing a significant suicidal risk (item 9 of the Beck Depression Inventory >1)
Randomization and Masking
Randomization took place at an individual level and was
conducted centrally by an independent statistician not otherwise
involved in the study using an automated computer-generated
random numbers table. Block randomisation, of size 2, was used
to ensure equal sample sizes across both conditions. Details
about the randomization procedure can be found elsewhere [16].
Study participants were not masked to their treatment allocation
because of the nature of the intervention. SCID interviewers
were, however, unaware of participants’ randomization status.
Steps taken to maintain blinding are described in detail
elsewhere [16]. In case of evidence for blinding breakdown, the
interviewer was changed to the second outcome interview. The
research staff conducting SCID interviews were not otherwise
involved in the study.
Procedures
All study participants had unrestricted access to care-as-usual
(CAU). CAU for sD entails visits to the general practitioner
(GP), but no treatment provided by mental health specialists. If
depressive symptoms deteriorate, the German
S3-Guideline/National Disease Management Guideline Unipolar
Depression recommends psychotherapy and the prescription of
antidepressant medication [21]. In our pragmatic study, we did
not interfere in CAU. Instead, we maintained a naturalistic CAU
condition to represent current clinical practice as far as possible.
It should also be noted that health care use was measured in
detail (see Measures), implying that we now can describe CAU
in great detail (see Table 1).
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Table 1. Mean annual per-participant costs (in €) by condition cumulative over the 12-month follow-up period (based on intention-to-treat sample, N=
406).
Incremental costsControl group, (n=204)Intervention group, (n=202)Cost categories
Difference, €Mean (SD), €Mean (SD), €
28910 (–)299 (–)Intervention
Health care costs
25117 (154)142 (142)General practitioner or
internist
−58175 (447)117 (308)Mental health care
7236 (363)243 (428)Other medical special-
ista
−75123 (1302)48 (679)In-patient care
−3535 (499)0 (-)Day care
−820 (57)12 (41)Antidepressants
Patient and family costs
20117 (246)137 (354)Private therapistb
−330 (65)27 (73)Copaymentsc
−522 (42)17 (34)Over-the-counter drugs
−61384 (857)323 (943)Informal care
−23120 (511)143 (455)Domestic help
128 (72)29 (77)Travel
Productivity losses
3031172 (2209)1475 (2498)Absenteeism
−3252021 (2781)1696 (1622)Presenteeism
136768 (1777)904 (989)Total health care costs
1434513 (5160)4655 (4674)Total societal costs
aphysiotherapist, occupational therapist.
bphysiotherapist without prescription.
cpatient’s contribution to prescribed medication.
Web-Based Guided Self-Help Intervention
The Web-based intervention, called GET.ON Mood Enhancer,
is an online multimedia interactive intervention consisting of 6
sessions. Each session takes about 30 minutes to complete, but
the amount of time spent on a session varies among users.
Participants were advised to carry out at least one, preferably 2
lessons per week. Intervention usage was monitored by logfile
analysis. On average, participants completed 4.93 of 6 sessions
(Multimedia Appendix 1). The mean treatment duration was
5.84 (SD 4.37) weeks [16]. The intervention was developed by
trained psychologists and therapists at the Leuphana University.
Participants created their own password to access the
intervention. Trial participants used the intervention free of
charge. The intervention was based on behavioral activation
and problem-solving therapy. The content of the intervention
was frozen during the trial. An emphasis was placed on
homework assignments to integrate newly acquired skills into
daily life. Therefore, participants had the option to receive a set
of about 42 standardized text-messages supporting them to
integrate the learned techniques into their lives. Participants
were also supported by an online-trainer, who provided written
feedback after each session and monitored adherence to the
intervention. In case of nonadherence, eCoach sent up to 3
reminders. The total time a trainer spent per participant was
approximately 3 hours. Trained and supervised graduate students
and health care professionals provided guidance. The guidance
focused on supporting participants to work through the exercises.
Trainers available on the Web did not provide therapeutic
support. Further details about the intervention can be found in
the study protocol [19].
Enhanced Usual Care
Participants in the control condition got access to an Web-based
psychoeducational intervention, which was based on the German
S3-Guideline/National Disease Management Guideline Unipolar
Depression [21]. It informed participants about evidence-based
treatments of depression should symptoms deteriorate. We thus
mimicked and enhanced usual care because we provided patients
with information that they may not always be offered thoroughly
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by their GP. Similar psycho-educational interventions have been
shown to be effective in reducing depressive symptoms and is
therefore suggested as a first-line intervention for early
manifestations of depression in the primary care setting [22].
Participants could go through the materials as often as they
want. However, we did not monitor its uptake and no additional
support was provided to participants in the CAU condition.
Outcome Measures
Self-reported measures (ie, EuroQol and SF-12) were collected
at baseline, posttreatment (6 weeks after randomization), and
6- and 12-month follow-up using a secured Web-based
assessment system (AES, 256-bit encrypted). The SCID
interviews at baseline and 6- and 12-month follow-up were
conducted by telephone.
Depression-Free Years (DFYs)
The main outcome in the cost-effectiveness analysis comprised
DFYs. DFYs were based on the number of depression-free
weeks up to the onset of a major depressive episode within the
12-month follow-up period. MDD was assessed according to
DSM-IV criteria as assessed by the telephone-administered
SCID [23,24] at 6- and 12-month follow-up covering the period
to the previous assessment. Time to onset of MDD was assessed
as accurately as possible using the Life Chart method as
developed by Lyketsos [25]. In this method, life events were
recalled using a calendar method where personal landmarks
were used to determine the presence of depressive symptoms
at each month during the follow-up period. During the interview,
the first day of a depressive episode was established. If the exact
day could not be established, the closest week (month) was
defined and the mid-point of that week (month) was used. The
interrater agreement in this study was substantial (Cohen
kappa=0.77).
Quality-Adjusted Life Years (QALYs)
QALYs were used as the outcome in the cost-utility analysis.
QALYs were based on the EQ-5D-3L (EuroQol) [26] and SF-6D
(a subset of items of the SF-12v1) [27]. The EuroQoL and the
SF-12 were assessed at baseline, posttreatment (6 weeks), and
6- and 12-month follow-up. The EQ-5D-3L comprises 5 items
covering 5 domains (mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression), each of which is rated
as causing “no problems,” “some problems,” or “extreme
problems.” Theoretically, the EQ-5D-3L generates 243 different
health states. Preference-based utilities for each of these health
states are available for various countries with “full health” and
“death” being anchored at 1 and 0, respectively. The SF-6D
contains 6 dimensions (each with between 2 and 5 levels) and
includes 6 items of the SF-12. The SF-6D generates 7500
different health states. Utility values were derived using
Brazier’s algorithm [28,29]. QALY health gains were estimated
by calculating the area under the curve (AUC) of linearly
interpolated EQ-5D-3L and the SF-6D utilities to cover the
whole follow-up period of 12 months. This method weighs the
12-month period by the respective utilities of each time period.
A QALY gain of 1 would thus indicate full health throughout
the 12-month trial period. For the main analysis, we used the
EQ-5D-3L QALY based on the UK tariffs [30]. For the
sensitivity analyses, we used the SF-6D QALYs because these
are known to be more sensitive to changes in mild conditions
[31].
Resource Use and Costing
We used the Trimbos and iMTA questionnaire for costs
associated with psychiatric illness (TiC-P) [32,33] for collecting
data on health care utilization and productivity losses in patients
with mental health conditions. We adapted the TiC-P for use in
Germany and used it at baseline and at 6- and 12-month
follow-ups. We computed health care costs, the patient’s
out-of-pocket costs, the costs for informal care provided by the
patient’s family and friends, and costs stemming from
productivity losses due to absenteeism and lesser productivity
while at work (presenteeism). Costs were expressed in Euro
and indexed for the year 2013 (index factor 1.04) based on the
German consumer price index [34]. Costs were converted to
pound sterling (£) using the purchasing power parities reported
by the Organization for Economic Cooperation and
Development. For the reference year 2013, €1 was equated to
£0.85.
Health Care Costs
We used 2 German guidelines for calculating health care costs
[35,36]. A list of unit cost prices (ie, outpatient care) was used
to compute the total health care costs on a per-participant basis
[36]. Unit cost prices were as follows: (1) €20.92 for a visit to
the GP, (2) €68.06 for an internal medicine consult, (3) €46.55
for a session with a psychiatrist, and (4) €81.44 for a session
with a psychotherapist. Hospital stays were computed at €335.52
for an in-patient day in a mental hospital and €306.41 for an
in-patient day in a hospital for psychosomatic medicine and
psychotherapy. Costs were estimated by multiplying the units
of resource use with corresponding unit cost prices.
Medication
The costs of prescribed medication were based on the German
drug registry (Rote Liste) [37]. The basis for calculating costs
of prescribed medication is the pharmacy retail price taking into
account a specific pharmacy and manufacture’s discount. The
rates of discount vary between private and statutory health
insurances [36]. Therefore, we weighted the mean costs of the
3 largest packages with the same agent based on the daily
defined dose by the statutory population share (89% of the
German population are statutorily insured).
Intervention Costs
The total costs for the Web-based cognitive-behavioral
intervention were estimated at €299 (£254) per participant by
the provider (GET.ON Institute) including €180 for providing
feedback by an eCoach. The total cost of the intervention was
based on the actual market price of this intervention that has
been determined by the provider. The GET.ON Institute aims
to transfer scientific knowledge related to the present research
into routine health care. This institute licenses the intervention
under study from the Leuphana University, Lueneburg, to
provide the intervention within routine preventive services of
health insurance companies in Germany. We assumed that the
cost of IT servers and infrastructure will increase if the
intervention is scaled up because more servers are needed.
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However, these fixed costs are subject to an economies of scale
effect (ie, marginal costs drop per additional user). The
per-participant costs for the psycho-educational intervention
were estimated at €10 (£9).
Patient and Family Costs
Out-of-pocket costs were directly obtained from participants.
Costs for traveling were valued at €0.30 per kilometre.
Opportunity cost (ie, time spent on the intervention) were valued
at €23.10 per hour. Costs of informal care were valued using a
shadow price of €18.33 per hour [36].
Costs of Productivity Losses
We followed the human capital approach to value productivity
losses [38]. Productivity losses can be caused by days not
worked (absenteeism) and by reduced efficiency while at work
(presenteeism). Lost workdays due to absenteeism were valued
at the corresponding gross average of participants’ income per
day. Lost workdays due to presenteeism were computed by
taking into account the number of work days for which the
participant reported reduced functioning weighted by an
inefficiency score for those days. Productivity losses from
unpaid work (ie, domestic tasks) were valued using a shadow
price of €18.33 per hour needed to pay for domestic help [36].
Analysis
The study was powered to demonstrate a risk reduction of 10%
between study conditions as statistically significant in a survival
analyses with alpha<.05 (2-tailed), a power of (1−beta)=.80
using survival analysis, and accounting for a 20% dropout
(calculated using PASS 12). However, the study was not
powered to statistically test differences in health economic
outcomes. Therefore, we took a probabilistic decision-making
approach for our health economic inferences [39]. We did not
discount costs and effects because the analysis was restricted
to a 12-month follow-up period.
While evaluating the clinical outcomes, we reported all analyses
in accordance to the CONSORT statement [40] (Multimedia
Appendix 2). Data were analyzed on an intention-to-treat basis
meaning that all participants were included in the analyses as
randomized. To this end, we used Cox proportional hazard
regression analyses to test differences in time to onset of MDD
(in weeks) between intervention and control group. Concurrent
use of antidepressants was included as covariate into the Cox
proportional hazard model (post hoc). As the use of
antidepressants was not a predictor of the outcome, it was
excluded from the final model.
To account for missing data in cost and utility data, we used the
regression imputation procedure in Stata version 13 (StataCorp)
to obtain required predicted values. Predictors of outcome and
dropout were identified by (logistic) regression analysis.
Identifying predictors of outcome helped us to obtain the most
likely values of the outcome whereas identifying predictors of
dropout allowed us to correct for bias that might arise by
differential loss-to-follow-up. We did not impute hospitalization
costs because only 3 participants (0.7%) were hospitalized
during the 12-month follow-up period leading to instable
imputations. Therefore, we reassessed the impact of
hospitalization costs on outcomes in a sensitivity analysis. At
baseline, mean EQ-5D utility values were the same in
intervention and control group (both groups: 0.74, SD=0.15).
Therefore, no baseline adjustments were made when calculating
QALYs. Differences in QALYs and DFYs between the
intervention and control groups were assessed using independent
samples t-tests.
In the cost-effectiveness analysis, the incremental
cost-effectiveness ratio (ICER) was based on the incremental
costs per unit of effect (DFY or QALY) gained. The
corresponding equation is ICER=(CostsINT–
CostsCTR)/(EffectsINT– EffectsCTR), where Costs are the annual
per-participant costs and Effects are the DFYs (QALYs) in
intervention and control group (subscripted with INT and CTR,
respectively). Sampling uncertainty in the ICER was handled
using nonparametric bootstrapping by resampling patient-level
data to generate 2500 simulations of the ICER. We bootstrapped
the SURE model (seemingly unrelated regression equations;
sureg command in Stata) to allow for correlated residuals of the
cost and effect equations. Bootstrapping was used to obtain
confidence intervals for cost-effectiveness ratios based on the
percentile method, since parametric techniques are inappropriate
for use on skewed variables and ratios. The bootstrapped ICERs
were plotted on a cost-effectiveness plane with effects along
the horizontal axis and costs along the vertical axis. A
cost-effectiveness acceptability curve (CEAC) was graphed to
assess the probability of the intervention being cost-effective
at varying willingness-to-pay (WTP) ceilings. All analyses
including uncertainty analyses were performed using Stata
version 13.
Sensitivity Analyses
We tested the robustness of the outcomes of the main analysis
in sensitivity analyses. First, the EQ-5D-3L might suffer from
ceiling effects when measuring QALY changes in people with
mild conditions. Therefore, we measured SF-6D QALYs, which
have been reported to be more sensitive to QALY changes in
milder conditions such as sD [31]. Second, we assessed the
impact of in-patient care on the ICER because in-patient care
is one of the main cost drivers and was surrounded by much
uncertainty since only 3 hospital admissions occurred in the
whole sample (0.7%, 3/406). Such outliers (driving costs in the
control condition) could lead to misleading results, and these
costs were removed in a sensitivity analysis.
Results
Sample Characteristics
In total, 406 participants were enrolled in the study (NINT=202;
NCTR=204). At the posttreatment stage, 366 participants (90.1%,
366/406) were still participating. At 6- and 12-month follow-up,
325 (80.1%, 325/406) and 286 (70.4%, 286/406) participants
completed the questionnaires, respectively. The CONSORT
flowchart (of the participants through the trial) can be found
elsewhere [16]. Dropout rates did not differ between
experimental and control conditions except for the 12-month
follow-up. Here, dropout was higher in the intervention group
(χ21 = 8.4, P=.004). Study dropout was not associated with
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baseline depressive symptom severity or any sociodemographic
factor. Participants’ characteristics at baseline are presented in
detail elsewhere [16]. In brief, the average participant was
female aged 45 years with an above average level of education
and employed.
Effects
The mean depression-free survival time within the 12-month
trial period was 43 weeks (95% CI 41-46) in the intervention
group and 37 weeks (95% CI 36-40) in the control group [16],
corresponding to 0.82 DFYs and 0.70 DFYs, respectively. The
incremental effectiveness of 0.82−0.70=0.12 DFYs was
statistically significant (95% CI 0.05-0.18; t404=3.37, P<.001).
Between-group differences in EQ-5D, QALY gains were not
statistically significant (intervention group: 0.78, SD=0.14 vs
control group: 0.77, SD=0.13; t404=−0.99, P=.32), but
incremental SF-6D QALY gains differed significantly between
study groups (intervention group: 0.71, SD=0.08 vs control
group: 0.67, SD=0.07; t404=−4.40, P<.001).
Costs
At baseline, mean total costs were €483 (£411) in the
intervention group and €528 (£449) in the control group, which
is only a small difference of €45 (£38), indicating that
randomization had been well balanced. Table 1 presents the
12-month accumulated per-participant costs for various cost
categories by study condition. The mean health care costs were
higher in the intervention group as compared with the control
condition. This difference can largely be explained by
differences in the costs of the intervention as compared with
the control condition with Web-based psycho-education (€299
vs €10). Patient and family’s out-of-pocket costs and the costs
stemming from changes in productivity losses remained quite
similar between study groups. Mean total costs, as seen from
both the health care and societal perspective, were hence slightly
higher in the intervention group as compared with the control
group (societal perspective: €143 (£121); health care
perspective: €136 (£116).
Societal Perspective
Table 2 shows the incremental cost, effects, and
cost-effectiveness ratios (based on 2500 bootstrap simulations)
for the main analysis and the sensitivity analyses and from both
the societal and health systems perspective. From a societal
perspective, the intervention resulted in a greater mean health
benefit (0.12 DFY gained) achieved at higher mean total costs
(€134; £114) as compared with enhanced CAU.
The cost-effectiveness plane, representing the 2500 bootstrap
replications, is shown in Figure 1. Most (62%) of the
bootstrapped ICERs fell in the north-east quadrant, indicating
a 62% probability that the intervention produces greater health,
but at greater costs than enhanced CAU. The remaining 38%
of ICERs fell in the south-east quadrant, indicating a 38%
probability that the intervention dominates enhanced CAU
because additional health gains are obtained for lesser costs. In
other words, at a willingness-to-pay (WTP) of €0, the probability
that the intervention must be regarded as more cost-effective
than CAU is 38%.
However, at a WTP of €7350 (£6248), €9680 (£8228), and
€20,000 (£17,000) for gaining a depression-free life-year, the
intervention’s probability of being more cost-effective than
CAU rises to 90%, 95%, and 99% (Figure 2).
The ICER based on QALY gains showed a small health benefit
(0.01 QALYs gained) for higher mean costs (€134; £114). As
seen in Figure 3, most of the simulated ICERs fell in the
north-east quadrant (49%; see also Table 2).
The intervention’s probability of dominating enhanced CAU
was 35% when taking the societal perspective. Assuming a
willingness-to-pay of €20,000 (£17,000) for gaining a QALY,
this probability rose to 60% (Figure 4).
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Table 2. Results of the main and sensitivity analyses (based on 2500 bootstrap simulations).
Distribution over the ICER planeMeanIncrementalIncrementalAnalysis and perspective
South-west
quadrant
South-east
quadrant
North-west
quadrant
North-east
quadrant
ICERa (95% CI)effects (95% CI)costs, € (95% CI)
Cost-effectiveness, DFYsb
-38%-62%1117 (−7546 to
11,737)
0.12 (0.05 to 0.18)134 (−827 to 1055)Societal
-17%-83%1125 (−1428 to
4715)
0.12 (0.05 to 0.18)135 (−146 to 418)Health care
Cost-utility, EQ-5D QALYsc
5%35%11%49%13,400d0.01 (−0.01 to 0.04)134 (−827 to 1055)Societal
2%16%14%68%13,500d0.01 (−0.01 to 0.04)135 (−146 to 418)Health care
Sensitivity analyses
-40%-60%4467 (−23,846 to
42,891)
0.03 (0.02 to 0.05)134 (−827 to 1055)SF-6D QALYse, societal
-17%-83%4500 (−5000 to
15,088)
0.03 (0.02 to 0.05)135 (−146 to 418)SF-6D QALYs, health
care
Without hospitalization costs
-30%-70%1942 (−5169 to
14,705)
0.12 (0.05 to 0.18)233 (−649 to 1155)Societal, DFY
---100%2042 (865 to 5562)0.12 (0.05 to 0.18)245 (119 to 374)Health care, DFY
26%3%58%13%23,300d0.01 (−0.01 to 0.04)233 (−649 to 1155)Societal, EQ-5D QALY
--84%16%24,500 (44220 to
−22,333)
0.01 (−0.01 to 0.04)245 (119 to 374)Health care, EQ-5D
QALY
aICER: Incremental cost-effectiveness ratio.
bDFYs: Depression-free years.
cEQ-5D QALYs: Quality-adjusted life years based on EuroQol.
dA dependably accurate 95% confidence interval for this distribution cannot be defined because there is no line through the origin that excludes alpha/2
of the distribution.
eSF-6D QALYs: Quality-adjusted life years based on SF-12.
J Med Internet Res 2017 | vol. 19 | iss. 1 | e5 | p.8http://www.jmir.org/2017/1/e5/
(page number not for citation purposes)
Buntrock et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 1. Scatterplot of 2500 replicates of the incremental cost-effectiveness ratio (mean differences in costs from a societal perspective and in
depression-free years) on the cost-effectiveness plane: Web-based guided self-help intervention vs enhanced usual care.
Figure 2. Cost-effectiveness acceptability curve showing the probability of the Web-based guided self-help intervention being cost-effective at varying
willingness-to-pay ceilings (based on 2500 replicates of the incremental cost-effectiveness ratio using mean differences in costs from a societal perspective
and depression-free years).
J Med Internet Res 2017 | vol. 19 | iss. 1 | e5 | p.9http://www.jmir.org/2017/1/e5/
(page number not for citation purposes)
Buntrock et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 3. Scatterplot of 2500 replicates of the incremental cost-effectiveness ratio (mean differences in costs from a societal perspective and in
quality-adjusted life years [QALYs]) on the cost-effectiveness plane: Web-based guided self-help intervention vs enhanced usual care.
Figure 4. Cost-effectiveness acceptability curve showing the probability of the Web-based guided self-help intervention being cost-effective at varying
willingness-to-pay ceilings (based on 2500 replicates of the incremental cost-effectiveness ratio using mean differences in costs from a societal perspective
and quality-adjusted life years [QALYs]).
Public Health Care Perspective
From a public health care perspective, the health benefit (0.12
DFY gained) was also achieved at higher costs (€135; £115).
In the cost-effectiveness plane, 83% of simulated ICERs fell in
the north-east quadrant with the remaining 17% in the south-east
quadrant (Table 2). The intervention’s probability to be more
cost-effective than enhanced CAU increased to 51% at a WTP
of €1250 (£1063) and became 90%, 95%, and 99% at a WTP
of €3140 (£2669), €3,920 (£3332), and €6000 (£5100),
respectively. From the societal perspective, the ICER from the
public health care perspective based on QALY gains showed a
small health benefit (0.01 QALYs gained) for higher mean costs
(€135). In the cost-effectiveness plane, 68% of the simulated
ICERs fell in the north-east quadrant (Table 2). The
intervention’s probability of dominating enhanced CAU was
16% when considering health care costs. Assuming a
willingness-to-pay of €20,000 (£17,000) for gaining a QALY,
this probability was 64%.
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Sensitivity Analyses
Using the SF-6D resulted in a greater incremental QALY gain
in favor of the intervention group (0.70 QALY, SD 0.08) as
compared with the control group (0.67 QALY, SD 0.07), which
was statistically significant (t404=4.40, P<.001). This agrees
with available evidence that the EQ-5D suffers from a ceiling
effect in less severe diseases [41]. At a WTP of €20,000 for
gaining one QALY the probability of being cost-effective was
84% (societal perspective) and 99% (health care perspective).
Hospital costs were higher in the control group so excluding
these costs resulted in higher ICERs (Table 2). From a societal
perspective and at a WTP of €20,000, the intervention’s
probability of being cost-effective then became 53%.
Discussion
Principal Findings
Our study was set out to evaluate the cost-effectiveness and
cost-utility of a Web-based guided self-help intervention to
prevent the onset of MDD in adults suffering from sD in
comparison with usual care enhanced with Web-based
psycho-education. Main outcomes were DFYs and QALYs.
Significantly more DFYs were gained in the intervention group
as compared with the control group. The probability that the
intervention is deemed to be cost-effective depends on the
willingness-to-pay (WTP) for a depression-free year. Assuming
that the intervention is considered to be cost-effective if its
likelihood of being cost-effective is greater than 90%, a WTP
of €7350 and above for gaining a DFY would make the
intervention cost-effective. While these DFY health gains were
not mirrored in EQ-5D QALY gains, they were observed in
SF-6D QALY gains with the latter being more sensitive to
change in milder conditions such as sD and therefore not
suffering as much from a ceiling effect as the EQ-5D does [31].
If society would be willing to pay €20,000 (£17000) for gaining
a QALY, the probability of being cost-effective will be 64%
for gaining an EQ-5D QALY and 84% for gaining a SF-6D
QALY.
Wider Context
Both burden of disease studies and cost of illness studies [1,2]
attest to the importance of cost-effective interventions that can
reduce the burden of depressive disorders on a wider scale.
Recent meta-analytic evidence suggests that it is possible to
prevent the onset of major depression using psychological
interventions [8]. Results of our study showed that a guided
eHealth intervention can successfully reduce the incidence of
diagnosed major depression [16]. In addition, some evidence
indicates that bibliotherapeutic self-help interventions for the
prevention of depression represent good value-for-money [15].
However, economic evaluations in the field of depression
prevention mainly relied on health-economic modelling
[12,13,42] with direct evidence stemming only from 2
randomized controlled trials [10,11]. Although some trial-based
economic evaluations of computerized cognitive-behavioral
interventions for treating depressive symptoms exist (ie,)
[43,44], to our knowledge, this is the first trial-based economic
evaluation of a Web-based intervention to prevent the onset of
major depression in an adult population with sD. Results from
our trial adds to the converging evidence pointing to the
effectiveness and cost-effectiveness (sometimes even
costs-savings) of depression prevention across a range of
outcomes.
Limitations
This study has some limitations. First, the time horizon of this
study was limited to 12 months. A recent meta-analysis showed
a small positive association between effects of preventive
interventions during the first months of follow-up, indicating
that with passing months, the intervention effects get somewhat
larger. However, meta-regression analyses suggested that the
effects of interventions are lower at longer follow-up periods
of 1 to 2 years [8]. Assuming diminishing long-term effects,
the cost-effectiveness of this particular intervention will also
decline. However, only few studies had longer follow-up periods
than 2 years. Thus, more research with longer follow-up periods
are needed to assess the long-term effectiveness and
cost-effectiveness of preventive (Web-based) interventions.
Second, we did not assess lifetime history of MDD at baseline,
and therefore we cannot be sure if we prevented first-ever onsets
of MDD or MDD recurrences. Future studies should thus clarify
whether Web-based guided self-help interventions are
cost-effective both for the prevention of first depression onset
and the prevention of recurrence. Third, costs were assessed
with the help of self-reports and may suffer from
under-reporting. However, the structured questionnaire used in
this study can be considered as valid instrument for recall
periods up to 3 months [45]. Finally, the trial has been conducted
in a highly-educated sample. Evidence suggests that better
adherence is predicted by higher education [46]. In our trial,
only 2% of participants were low educated. Hence, we cannot
predict the uptake of such an intervention in less educated people
or among people with a lower socioeconomic status. However,
we used an open recruitment strategy in our trial mimicking the
way how people will be recruited for eHealth interventions in
the future, thus providing ecological validity to the sample on
which this study is based. In other words, the trial sample
reflects the population segments that are interested in engaging
in a Web-based intervention. However, one conclusion drawn
from this trial is that not all people who are in need of
psychological interventions could be reached via the Internet.
The applicability of Web-based interventions is related to (1)
the acceptance of such interventions by the target population
(ie, preferences for different treatment modalities, such as
face-to-face interventions) and (2) the availability of technical
requirements (ie, reliable access to the Internet).
Clinical Implications and Future Research
Current guidelines on depression treatment (such as the NICE
guideline and the Dutch Multidisciplinary Guideline for
Depressive Disorder) recommend low-intensity psychosocial
interventions (ie, computerized cognitive behavioral therapy)
to manage (persistent) sD symptoms and mild-to-moderate
depression [22]. Our study supports this recommendation by
showing that an eHealth intervention may not only restore health
in people with sD, but in addition reduces the risk of developing
a major depressive disorder. Findings from our study also add
J Med Internet Res 2017 | vol. 19 | iss. 1 | e5 | p.11http://www.jmir.org/2017/1/e5/
(page number not for citation purposes)
Buntrock et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
that delivering cognitive-behavioral therapy over the Internet
has a high probability of being cost-effective to prevent the
onset of new depressive episodes. Given low participation rates
in face-to-face preventive services and the potential to scale up
Web-based interventions to efficiently alleviate the disease
burden caused by MDD, it would be worthwhile to integrate
such a Web-based intervention into routine practice. However,
there are some opportunities and risks that need to be taken into
account when scaling up this intervention. First, the feedback
provided by an individual trainer on the Web in this Web-based
intervention hinders scaling up the intervention. A recent review
of randomized controlled trials showed that unguided
interventions can also be effective (with lower adherence rates
compared to guided interventions) [47]. To be more precise, in
our study, out of the 202 participants who were initially assigned
to the intervention, 138 (68.3%, 138/202) were intervention
completers. This compares favorably with an unguided
Internet-based intervention for the treatment of sD that was
completed by 48.3% (49/102) of participants [48]. Providing
guidance may not only affect the outcome and cost-effectiveness
of the intervention but also the target group’s willingness to use
such an intervention and thereby influencing the effects of such
an intervention at population level. It is therefore not possible
to predict the effects of this particular Web-based intervention
at population level when it is offered without guidance by an
eCoach. In addition, there are no guarantees that adherence and
(by proxy) effectiveness will be maintained if Web-based
preventive interventions are scaled up in the population. For
example, Christensen et al reported that less than 1% of public
registrants using a preventive intervention delivered openly on
a website completed all modules [49]. Second, an unanswered
question refers to how Web-based interventions could be rolled
out to the population. For example, in the UK and the
Netherlands, Internet-delivered cognitive behavioral
therapy (CBT) is already prescribed by GPs [22]. In addition,
Web-based interventions could be promoted independently at
the GP’s (ie, promotion videos in the GP’s waiting rooms).
However, a challenge in preventing depression is that most
individuals at risk of developing a major depression do not show
up in primary care. Therefore, innovative approaches are needed
to reach these groups, for example through a systematic mental
health screening of all people in specific settings (ie,
occupational setting or universities) and to motivate those at
risk to engage in preventive interventions (ie, acceptance
facilitating interventions) [50]. However, such strategies do not
guarantee uptake either. Third, the costs of the Web-based
intervention were calculated without considering economies of
scale effect. Economies of scale refer to the reduction in the
cost per treatment of an intervention as a result of increasing
the number of clients. Economies of scale arise because many
of the costs associated with the Web-based intervention are
fixed and not dependent on the number of clients (ie, hosting
the intervention on a server) and thus increasing the intervention
output reduces the fixed cost per treatment. Hence, we assume
that the cost of IT infrastructure (ie, the per-client cost of servers
to host the intervention) will be cheaper per additional client if
the intervention is offered on a larger scale. Economies of scale
might also reduce variable costs (ie, therapist’s support per
participant) because therapists become more efficient through
better organization and experience. However, the same technical
resources available in the research setting (ie, reasonable Internet
connections) may not be available when the intervention is
scaled up. Finally, for some individuals a self-help approach
might not be sufficient [51]. Some individuals may feel unable
to apply psychotherapeutic self-help strategies. Some techniques
could be inappropriately implemented by participants without
guidance by an eCoach. One could argue that it is easier to
observe and react to early signs of deterioration in face-to-face
interventions as compared with Web-based interventions.
Another potential negative effect of self-help interventions could
be a delay in help-seeking leading to a further deterioration of
symptoms, if the initial low-intensity self-help intervention
should not be sufficient. Hence, multiple approaches to reach
the target population are needed in successful depression
prevention programs. Thus, future studies should evaluate the
preventive effects of unguided Web-based interventions on the
onset of MDD and compare the cost-effectiveness of unguided
and guided interventions. In addition, implementation studies
should be conducted to obtain real world effects of such
interventions and to gather knowledge about the willingness to
use these interventions in specific population segments (ie, in
low-educated people, in a rural setting, or among people with
lower socioeconomic status).
Conclusions
Given the evidence for the efficacy of psychological
interventions to prevent depression and the potential scalability
and cost-effectiveness of Web-based interventions, large-scale
dissemination of these interventions might be a promising
strategy to alleviate depression’s disease burden in an affordable
way and on a wide scale. However, before a nationwide
dissemination could be considered, future studies need to
evaluate the preventive effects of unguided Web-based
interventions on the onset of MDD and compare the
cost-effectiveness of unguided and guided interventions.
Moreover, implementation studies are needed to obtain real
world effects of such interventions and to gather knowledge
about the willingness to use these interventions in specific
population segments (ie, in low-educated people, in a rural
setting, or among people with lower socioeconomic status).
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